Trials / Conditions / MSI-H Solid Malignant Tumor
MSI-H Solid Malignant Tumor
3 registered clinical trials studyying MSI-H Solid Malignant Tumor — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Beta-only IL-2 ImmunoTherapY Study NCT05086692 | Medicenna Therapeutics, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | Combination Immunotherapy in Rare Cancers Under InvesTigation NCT04969887 | Olivia Newton-John Cancer Research Institute | Phase 2 |
| Recruiting | A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to NCT03941574 | Shanghai Henlius Biotech | Phase 2 |